A61P 17 - Drugs for dermatological disorders

Patents for A61P 17 - Drugs for dermatological disorders (106,455)
12/2001
12/06/2001	CA2410912A1 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof
12/06/2001	CA2410903A1 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
12/06/2001	CA2410735A1 Use of adnf for enhancing learning and memory
12/06/2001	CA2410660A1 Cyclohexylamine derivatives as subtype selective nmda receptor antagonists
12/06/2001	CA2410489A1 Human kcnq5 potassium channel, methods and compositions thereof
12/06/2001	CA2410470A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
12/06/2001	CA2410453A1 Neuroprotective peptides
12/06/2001	CA2410087A1 Mammalian protein phosphatases identified by in-silico analysis
12/06/2001	CA2410084A1 Transporters and ion channels
12/06/2001	CA2409927A1 Combinations of an endothelin receptor antagonist and an antiepileptic compound having pain alleviating properties or analgesic
12/06/2001	CA2409921A1 Cosmetic composition comprising human serum albumin obtained from transgenic non-human animals
12/06/2001	CA2409617A1 2,7-naphthyridine derivatives
12/06/2001	CA2409311A1 Regulators of apoptosis
12/06/2001	CA2409006A1 Biciclic cyclohexylamines and their use as nmda receptor antogonists
12/06/2001	CA2406979A1 Indole derivatives with vascular damaging activity
12/05/2001	EP1160322A2 Human melanocyte stimulating hormone receptors
12/05/2001	EP1160255A1 Monovalent antibody fragments
12/05/2001	EP1160005A1 Nanoemulsion based on anionic polymers, and uses thereof especially in the cosmetic, dermatological, pharmaceutical and/or ophthalmic fields
12/05/2001	EP1159966A2 Composition for the treatment of psoriasis
12/05/2001	EP1159420A1 Human pancreas and pancreatic cancer associated gene sequences and polypeptides
12/05/2001	EP1159419A1 Promotion or inhibition of angiogenesis and cardiovascularization
12/05/2001	EP1159418A2 Muc-1 antagonists and methods of treating immune disorders
12/05/2001	EP1159417A2 Polynucleotides and proteins encoded thereby
12/05/2001	EP1159408A2 Hermansky pudlak syndrome protein-interacting proteins and methods of use thereof
12/05/2001	EP1159300A2 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith
12/05/2001	EP1159292A2 Compounds having growth hormone releasing activity
12/05/2001	EP1159284A1 33 human secreted proteins
12/05/2001	EP1159280A2 Thiazoloindolinone compounds
12/05/2001	EP1159265A1 C-16 unsaturated fp-selective prostaglandins analogs
12/05/2001	EP1159061A1 Chemical method for making pyrithione particle dispersions
12/05/2001	EP1159000A2 Preparation for the treatment of pigmentation disorders
12/05/2001	EP1158996A1 Novel amide derivatives as growth hormone secretagogues
12/05/2001	EP1158988A2 Corticosteroid formulation
12/05/2001	EP1158975A1 Use of isoflavones and/or african plum extracts for preparing a composition designed to inhibit 5$g(a)-reductase activity, in pharmacology particularly in dermatology, in cosmetics and as food additive
12/05/2001	EP1158958A1 Improved powdery pharmaceutical compositions for inhalation
12/05/2001	EP1158859A1 Iodine preparation compositon
12/05/2001	EP0859596B1 Gel formulations containing growth factors
12/05/2001	EP0851856B1 Indole derivatives as melatoninergic analogues
12/05/2001	EP0814815A4 Poly(hydroxy acid)/polymer conjugates for skin applications
12/05/2001	EP0814800B1 Water-based topical cream containing nitroglycerin; method of preparation and use thereof
12/05/2001	EP0745075B1 6-substituted mycophenolic and derivatives with immunosuppressive activity
12/05/2001	EP0745071B1 4-amino 6-substituted mycophenolic acid and derivatives with immunosuppressive activity
12/05/2001	EP0445255B2 USE OF HYALURONIC ACID IN COMBINATION WITH ASCORBIC ACID, ANTITUMOUR AGENTS AND/OR NSAIDs FOR TREATING CANCER
12/05/2001	CN1325452A Method for the preparation of quercetin and isoquercetin derivatives
12/05/2001	CN1325408A Compounds with growth hormone releasing propenties
12/05/2001	CN1325390A 2-ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents
12/05/2001	CN1325389A 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents
12/05/2001	CN1325384A Anthranilic acid amides and the use thereof as medicaments
12/05/2001	CN1325303A Tocopherols, tocotrienols, other chroman and side chain derivatives and uses
12/05/2001	CN1325302A Use of dialkylfumarates
12/05/2001	CN1325297A Cosmetic composition
12/05/2001	CN1325291A Anti-inflammatory and antimicrobial uses for bioactive glass compositions
12/05/2001	CN1325271A Compositions of restricted cells capable of rapid growth which produce proliferation suppressive materials, and uses thereof
12/05/2001	CN1324951A High-efficiency expression and application of human recombinant interferon B
12/05/2001	CN1324655A Ointment for treating burns and scalds and its prepn.
12/05/2001	CN1324649A Dressing for treating burns and scalds
12/05/2001	CN1324645A Compound acne-treating tea and its prepn.
12/05/2001	CN1324642A Compound tea for treating psoriasis and its prepn.
12/05/2001	CN1324637A Condyloma acuminata treating medicine
12/05/2001	CN1324630A Medicine for treating burns and scalds and its prepn.
12/05/2001	CN1324607A Anti-fungus agent for local treatment of fungus infection of finger and its peripheral tissue and controllable releasable system of keratin-dissolving agnt
12/05/2001	CN1075816C Methods for in vivo reduction of nitric oxide levels and compositions sueful therefor
12/05/2001	CN1075809C Novel vitamin D analogues
12/05/2001	CN1075722C Fungicidal compositions containing bifonazole
12/04/2001	US6326510 Skin disorders; anticancer agents
12/04/2001	US6326398 Oxamic acids and derivatives as thyroid receptor ligands
12/04/2001	US6326385 Administering poltassium channel modulator
12/04/2001	US6326359 Adenosine A2A receptor agonists as antiinflammatory agents
12/04/2001	US6326352 Compounds and methods for modulating cell adhesion
12/04/2001	US6325994 Cosmetic composition comprising a styrene/acrylate copolymer and a fatty phase
12/01/2001	CA2347276A1 I g e-dependent histamine-releasing factor (hrf) receptor, hrf-binding peptides and nucleic acids encoding the same, and uses thereof
11/2001
11/29/2001	WO2001090334A2 Drug metabolizing enzymes
11/29/2001	WO2001090311A1 Novel probiotics for pet food applications
11/29/2001	WO2001090186A1 Methods for identifying modulators of the interaction between lap (latency associated peptide) and intergrin alpha.v.beta.3 and medical use thereof
11/29/2001	WO2001090156A2 Card domain containing polypeptides, encoding nucleic acids, and methods of use
11/29/2001	WO2001090129A2 Prophylactic and therapeutic treatment of infectious, autoimmune and allergic diseases with mono and disaccharide-base compounds
11/29/2001	WO2001090110A1 Macrolides
11/29/2001	WO2001090104A2 -(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as modulators of protein kinases
11/29/2001	WO2001090103A2 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as protein kinase modulators
11/29/2001	WO2001090101A1 Arylmethylamine derivatives for use as tryptase inhibitors
11/29/2001	WO2001090100A1 Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides
11/29/2001	WO2001090095A1 Thiadiazole compounds useful as inhibitors of cysteine activity dependent enzymes
11/29/2001	WO2001090086A1 A polymorph of 5-(4-aminosulfonyl-3-fluorophenyl)-4-cyclohexyl-2-methyloxazole
11/29/2001	WO2001090083A1 1,4-diazepan-2,5-dione derivatives and their use as nk-1 receptor antagonists
11/29/2001	WO2001090076A1 Fluoroalkoxy-substituted benzamide dichloropyridinyl n-oxide pde4 inhibitor
11/29/2001	WO2001090074A2 BENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a)
11/29/2001	WO2001090070A2 Caspase inhibitors and uses thereof
11/29/2001	WO2001090068A2 Mannich base prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use a modulators of protein kinases
11/29/2001	WO2001090063A2 Prodrug of an ice inhibitor
11/29/2001	WO2001090060A1 Disulfide derivatives useful for treating allergic diseases
11/29/2001	WO2001090059A1 Aniline disulfide derivatives for treating allergic diseases
11/29/2001	WO2001090047A1 Novel mmp-2/mmp-9 inhibitors
11/29/2001	WO2001089593A1 Transfection system
11/29/2001	WO2001089569A1 Combinations of enzyme inhibitor-containing preparations and the use thereof
11/29/2001	WO2001089558A2 Formulations and use of activated protein c and protein c zymogen for treating hypercoagulable states
11/29/2001	WO2001089556A1 Inhibition of smad3 to prevent fibrosis and improve wound healing
11/29/2001	WO2001089552A1 Modulaton of alpha-6 integrin-mediated responses
11/29/2001	WO2001089547A1 Antioxidant and skin preparations for external use
11/29/2001	WO2001089540A1 Use of egg white and egg white fractions for tissue regeneration
11/29/2001	WO2001089536A2 Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders

1 ... 846 847 848 849 850 851 852 853 854 855 856 857 858 859 860 861 862 863 864 865 866 ... 1065